NASDAQ:DOX - Amdocs Stock Price, Forecast & News

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs declared a quarterly dividend on Tuesday, November 12th. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.285 per share on Friday, January 24th. This represents a $1.14 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend is Monday, December 30th. View Amdocs' Dividend History.

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings results on Tuesday, November, 12th. The technology company reported $1.08 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.08. The technology company earned $1.03 billion during the quarter, compared to analysts' expectations of $1.03 billion. Amdocs had a return on equity of 15.98% and a net margin of 11.73%. Amdocs's quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.99 earnings per share. View Amdocs' Earnings History.

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Amdocs.

Amdocs will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Amdocs updated its first quarter 2020 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of $1.02-1.08 for the period, compared to the Thomson Reuters consensus estimate of $1.11. The company issued revenue guidance of $$1.015-1.055 billion, compared to the consensus revenue estimate of $$1.04 billion.

3 brokerages have issued 1-year price targets for Amdocs' stock. Their forecasts range from $72.00 to $83.00. On average, they expect Amdocs' stock price to reach $76.67 in the next year. This suggests a possible upside of 3.1% from the stock's current price. View Analyst Price Targets for Amdocs.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Amdocs.

News stories about DOX stock have trended very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Amdocs earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned media stories about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Amdocs.

Amdocs saw a increase in short interest in December. As of December 31st, there was short interest totalling 3,170,000 shares, an increase of 6.4% from the December 15th total of 2,980,000 shares. Based on an average daily volume of 660,900 shares, the days-to-cover ratio is currently 4.8 days. Currently, 2.4% of the company's stock are sold short. View Amdocs' Current Options Chain.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), Leidos (LDOS), Gartner (IT), EPAM Systems (EPAM), Booz Allen Hamilton (BAH), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Forrester Research (FORR), Unisys (UIS), The Hackett Group (HCKT) and Servicesource International (SREV).

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AbbVie (ABBV), Home Depot (hd), AT&T (T), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Activision Blizzard (ATVI), Comcast (CMCSA), Boeing (BA), Caterpillar (CAT) and Target (TGT).

Amdocs' stock is owned by many different of retail and institutional investors. Top institutional shareholders include PGGM Investments (0.34%), Boston Trust Walden Corp (0.15%), State of Alaska Department of Revenue (0.06%), Zurcher Kantonalbank Zurich Cantonalbank (0.06%), CHURCHILL MANAGEMENT Corp (0.05%) and Janney Montgomery Scott LLC (0.03%).

DOX stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Boston Trust Walden Corp, Douglass Winthrop Advisors LLC, CenturyLink Investment Management Co, Henry James International Management Inc., First Hawaiian Bank, Janney Montgomery Scott LLC and Wedge Capital Management L L P NC.

DOX stock was acquired by a variety of institutional investors in the last quarter, including CHURCHILL MANAGEMENT Corp, Convergence Investment Partners LLC, Orrstown Financial Services Inc., Exchange Traded Concepts LLC, Assenagon Asset Management S.A., State of Alaska Department of Revenue, We Are One Seven LLC and OLD National Bancorp IN.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $74.38.

Amdocs has a market capitalization of $10.02 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.View Additional Information About Amdocs.

The official website for Amdocs is http://www.amdocs.com/.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]